Diseases [C] » Digestive System Diseases [C06] » Pancreatic Diseases
Hierarchy View
Subtype Terms (8)
Congenital Hyperinsulinism
16 drugs (13 approved, 3 experimental)
Cystic Fibrosis
309 drugs (156 approved, 153 experimental)
Exocrine Pancreatic Insufficiency
23 drugs (12 approved, 11 experimental)
Pancreatic Cyst
5 drugs (4 approved, 1 experimental)
Pancreatic Fistula
11 drugs (10 approved, 1 experimental)
Pancreatic Neoplasms
1165 drugs (343 approved, 822 experimental)
Pancreatitis
97 drugs (71 approved, 26 experimental)
Approved Indicated Drugs (2)
Phase 2 Indicated Drugs (6)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (12)
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (38)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
